Evidence map›Paper›PMID 37342514›Full record

ReviewApplied biosafety : journal of the American Biological Safety Association2023

The Biosafety Research Road Map: The Search for Evidence to Support Practices in Human and Veterinary Laboratories.

Stuart D Blacksell, Sandhya Dhawan, Marina Kusumoto, Kim Khanh Le, Kathrin Summermatter, Joseph O'Keefe, Joseph Kozlovac, Salama Suhail Almuhairi, Indrawati Sendow, Christina M Scheel and 6 more

Open access · hybridAbstract readReview
In one paragraph

Review in Applied biosafety : journal of the American Biological Safety Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Biosafety and biosecurity forClinical microbiology reviews · 2026
    Review
  5. Review
  6. Piercing Insights: Uncovering the Gaps in Guidance for Body Jewelry in Biological Laboratories.Applied biosafety : journal of the American Biological Safety Association · 2025
    Article
  7. Dengue Virus Biosafety: An Analysis of Evidence, Global Inconsistencies, and Risk Gaps.Applied biosafety : journal of the American Biological Safety Association · 2025
    Review
  8. Findings and Recommendations of the RAV3N Applied Biorisk and Biosafety Gap Assessment Workshop.Applied biosafety : journal of the American Biological Safety Association · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. The Biosafety Research Road Map: The Search for Evidence to Support Practices in the Laboratory-Mpox/Monkeypox Virus.Applied biosafety : journal of the American Biological Safety Association · 2023
    Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 13 institutions in 11 countries.

Stuart D BlacksellMahidol-Oxford Tropical Research Medicine Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Sandhya DhawanMahidol-Oxford Tropical Research Medicine Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Marina KusumotoMahidol-Oxford Tropical Research Medicine Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Kim Khanh LeMahidol-Oxford Tropical Research Medicine Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Kathrin SummermatterInstitute for Infectious Diseases, University of Bern, Bern, Switzerland.ORCID https://orcid.org/0000-0001-5519-5966
Joseph O'KeefeMinistry for Primary Industries, Wellington, New Zealand.
Joseph KozlovacUnited States Department of Agriculture, Agricultural Research Service, Beltsville, Maryland, USA.
Salama Suhail AlmuhairiAbu Dhabi Agriculture and Food Safety Authority, Abu Dhabi, United Arab Emirates.
Indrawati SendowResearch Center for Veterinary Science, National Research and Innovation Agency, Indonesia.
Christina M ScheelWHO Collaborating Center for Biosafety and Biosecurity, Office of the Associate Director for Laboratory Science, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Anthony AhumibeNigeria Centre for Disease Control and Prevention, Abuja, Nigeria.ORCID https://orcid.org/0000-0002-4651-4424
Zibusiso M MasukuNational Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
Allan M BennettUK Health Security Agency, Porton Down, Salisbury, United Kingdom.
Kazunobu KojimaDepartment of Epidemic and Pandemic Preparedness and Prevention, World Health Organization (WHO), Geneva, Switzerland.
David R HarperThe Royal Institute of International Affairs, London, United Kingdom.
Keith HamiltonWorld Organisation for Animal Health (OIE), Paris, France.
Mahidol University · THAbu Dhabi Health Services · AEAgricultural Research Service · USCenters for Disease Control and Prevention · UGChatham House · GBMinistry for Primary Industries · NZNational Health Laboratory Service · ZANational Research and Innovation Agency · IDNigeria Centre for Disease Control · NGOrganisation Mondiale de la Santé Animale · FRUK Health Security Agency · GBUniversity of Bern · CHWorld Health Organization · CH

Funding

World Health Organization 001
6 · The paper itself

Abstract

Introduction: Lack of evidence-based information regarding potential biological risks can result in inappropriate or excessive biosafety and biosecurity risk-reduction strategies. This can cause unnecessary damage and loss to the physical facilities, physical and psychological well-being of laboratory staff, and community trust. A technical working group from the World Organization for Animal Health (WOAH, formerly OIE), World Health Organization (WHO), and Chatham House collaborated on the Biosafety Research Roadmap (BRM) project. The goal of the BRM is the sustainable implementation of evidence-based biorisk management of laboratory activities, particularly in low-resource settings, and the identification of gaps in the current biosafety and biosecurity knowledge base. Methods: A literature search was conducted for the basis of laboratory design and practices for four selected high-priority subgroups of pathogenic agents. Potential gaps in biosafety were focused on five main sections, including the route of inoculation/modes of transmission, infectious dose, laboratory-acquired infections, containment releases, and disinfection and decontamination strategies. Categories representing miscellaneous, respiratory, bioterrorism/zoonotic, and viral hemorrhagic fever pathogens were created within each group were selected for review. Results: Information sheets on the pathogens were developed. Critical gaps in the evidence base for safe sustainable biorisk management were identified. Conclusion: The gap analysis identified areas of applied biosafety research required to support the safety, and the sustainability, of global research programs. Improving the data available for biorisk management decisions for research with high-priority pathogens will contribute significantly to the improvement and development of appropriate and necessary biosafety, biocontainment and biosecurity strategies for each agent.

Indexed as

biosafety gapbioterrorism/zoonotic pathogensmiscellaneous pathogensrespiratory pathogensviral hemorrhagic fevers

Identifiers

PMID37342514
PMCPMC10277988
OpenAlexW4376618204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.